BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ang C, Doyle E, Branch A. Bisphosphonates as potential adjuvants for patients with cancers of the digestive system. World J Gastroenterol 2016; 22(3): 906-916 [PMID: 26811636 DOI: 10.3748/wjg.v22.i3.906] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Alhakamy NA, Al-rabia MW, Rizg WY, Alghaith AF, Ahmed OAA, Fahmy UA. Conjugation of bisphosphonates with scorpion venom enhanced apoptotic activities in pancreatic cancer cells.. [DOI: 10.1101/2022.08.30.505790] [Reference Citation Analysis]
2 Zhang Z, Li D, Yun H, Tong J, Liu W, Chai K, Zeng T, Gao Z, Xie Y. Opportunities and challenges of targeting c-Met in the treatment of digestive tumors. Front Oncol 2022;12:923260. [DOI: 10.3389/fonc.2022.923260] [Reference Citation Analysis]
3 Bjelić D, Finšgar M. Bioactive coatings with anti-osteoclast therapeutic agents for bone implants: Enhanced compliance and prolonged implant life. Pharmacol Res 2022;176:106060. [PMID: 34998972 DOI: 10.1016/j.phrs.2022.106060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Alhakamy NA, Ahmed OAA, Fahmy UA, Md S. Apamin-Conjugated Alendronate Sodium Nanocomplex for Management of Pancreatic Cancer. Pharmaceuticals (Basel) 2021;14:729. [PMID: 34451826 DOI: 10.3390/ph14080729] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
5 Mbese Z, Aderibigbe BA. Bisphosphonate-Based Conjugates and Derivatives as Potential Therapeutic Agents in Osteoporosis, Bone Cancer and Metastatic Bone Cancer. Int J Mol Sci 2021;22:6869. [PMID: 34206757 DOI: 10.3390/ijms22136869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
6 Shao Z, Pan H, Tu S, Zhang J, Yan S, Shao A. HGF/c-Met Axis: The Advanced Development in Digestive System Cancer. Front Cell Dev Biol 2020;8:801. [PMID: 33195182 DOI: 10.3389/fcell.2020.00801] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
7 Cheng XB, Fu B, Li XZ, Jiang Y. Prognostic value of long non-coding RNA ATB in digestive system cancers: A meta-analysis. Pathol Res Pract 2020;216:152949. [PMID: 32307201 DOI: 10.1016/j.prp.2020.152949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Osadchuk AM, Davydkin IL, Gricenko TA, Osadchuk MA. Gastroesophageal reflux disease and esophagitis associated with the use of drugs: the modern state of the problem. Terapevticheskii arkhiv 2019;91:135-40. [DOI: 10.26442/00403660.2019.08.000228] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wen DT, Xu Z, Xuan ML, Liang GR, Zheng WL, Liang XF, Xiao J, Wang XY. Prognostic Effect of Bisphosphonate Exposure for Patients With Diagnosed Solid Cancer: A Systematic Review With Meta-Analysis of Observational Studies. Front Oncol 2018;8:495. [PMID: 30420942 DOI: 10.3389/fonc.2018.00495] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Zhang H, Feng Q, Chen WD, Wang YD. HGF/c-MET: A Promising Therapeutic Target in the Digestive System Cancers. Int J Mol Sci 2018;19:E3295. [PMID: 30360560 DOI: 10.3390/ijms19113295] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
11 Wang HJ, Liu Y, Zhou BJ, Zhang ZX, Li AY, An R, Yue B, Fan LQ, Li Y. Inhibitory effects of CP on the growth of human gastric adenocarcinoma BGC-823 tumours in nude mice. J Int Med Res 2018;46:1756-66. [PMID: 29569987 DOI: 10.1177/0300060518761505] [Reference Citation Analysis]